Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2003
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362060A2 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362053A2 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362034A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1362030A1 Novel benzoylguanidine salt
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361899A2 Devices and methods for the treatment of cancer
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1361877A1 Pharmaceutical dosage forms of epothilones for oral administration
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1361869A2 Transdermal therapeutic system containing testosterone and method for the production thereof
11/19/2003EP1361868A1 Novel modified release formulation
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1157023B1 C-21 modified epothilones
11/19/2003EP1124549B1 Water-miscible pharmaceutical compositions of paclitaxel
11/19/2003EP1121107B1 Sertraline oral concentrate
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0967997B1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
11/19/2003EP0914830B1 Neovascularization inhibitor containing tissue factor pathway inhibitor
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0767673B1 Methods for reduced renal uptake of antibody fragments
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457340A Petrides and derivatives thereof showing cell attachment, spreading and detachment activity
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1457261A Method and compositions for prevention or treatment of cancer
11/19/2003CN1457259A Method for preventing and curing diseases of immune system and remedy for carrying out said method
11/19/2003CN1456566A Preparation of platinum (Ôàí) complex containing ether bond carboxylic radical as ligand
11/19/2003CN1456561A Preparations of leucovorin and its carbonates
11/19/2003CN1456323A Aitongkang against pains from cancers
11/19/2003CN1456276A Medicines for treating thyroma and hydatoncus
11/19/2003CN1456222A Preparation of composite mylabris pills
11/19/2003CN1456182A Fatty acid synthetase inhibitor, preparing method and application thereof
11/19/2003CN1456163A Oral medicine of leucovocin calcium and its preparing method
11/19/2003CN1456162A Injection of leucovorin calcium and its preparing method
11/19/2003CN1456150A Garlicin injection preparation
11/19/2003CN1128157C Conjugate of lidamycin with active fragment of monoclonal antibody
11/19/2003CN1128155C Colored mistletoe herb goycoprotein extraction and its medicine composite and preparation
11/19/2003CN1128149C 6,9-disubsituted 2-[trans-(4-aminocyclohexyl)amino]purines
11/19/2003CN1128139C New piperazine derivatives and its prepn.
11/19/2003CN1127984C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative
11/19/2003CN1127982C Antitumor cell-protein preparation
11/19/2003CN1127972C Medicine for cancers and its preparation
11/19/2003CN1127966C 'Hehe' ointment and its preparing process
11/19/2003CN1127952C Anticancer medicine composition
11/18/2003US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649643 Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyase
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649613 Diacylhydrazine derivatives
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649607 Compositions and methods for treating or preventing convulsions or seizures
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649411 Also using ADNF III nucleic acid probes to detect the presence of pathologically proliferating cells in human tissues.
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649373 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene
11/18/2003US6649185 For the treatment of cancer; particularly, the formulation can be used to treat haematological malignancies
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003US6649168 Pharmaceutical compositions comprising TGF-beta
11/18/2003US6649163 Treatment and diagnosis of cancer
11/18/2003US6649157 Treating a Ras-mediated cell proliferative disorder in a mammal, by administering a modified adenovirus, modified HSV, modified vaccinia virus or modified parapoxvirus orf virus resulting in lysis of the proliferating cells.
11/18/2003CA2143845C Self-assembling recombinant papillomavirus capsid proteins
11/17/2003CA2429483A1 Immunointeractive molecules
11/17/2003CA2386759A1 Therapeutic uses of peroxometallic compounds
11/13/2003WO2003093793A2 Binary or polynary targeting and uses thereof
11/13/2003WO2003093478A1 Immunoconjugates for the treatment of tumours
11/13/2003WO2003093476A1 Vector with modified protease-dependent tropism
11/13/2003WO2003093463A1 Improved viral purification methods
11/13/2003WO2003093456A1 Soya cell strains with high isoflavone content
11/13/2003WO2003093455A2 Adenovirus vectors for immunotherapy
11/13/2003WO2003093443A2 Alcam and alcam modulators
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093409A2 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003WO2003093320A2 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses
11/13/2003WO2003093317A1 Antibody to human insulin-like growth factor
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093287A1 Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses
11/13/2003WO2003093275A1 A bryostatin composition
1 ... 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 ... 2211